Early Activation of Apoptosis and Caspase-independent Cell Death Plays an Important Role in Mediating the Cytotoxic and Genotoxic Effects of WP 631 in Ovarian Cancer Cells

  • Gajek, Arkadiusz (Department of Thermobiology, Faculty of Biology and Environmental Protection, University of Lodz) ;
  • Denel-Bobrowska, Marta (Department of Thermobiology, Faculty of Biology and Environmental Protection, University of Lodz) ;
  • Rogalska, Aneta (Department of Thermobiology, Faculty of Biology and Environmental Protection, University of Lodz) ;
  • Bukowska, Barbara (Department of Thermobiology, Faculty of Biology and Environmental Protection, University of Lodz) ;
  • Maszewski, Janusz (Department of Cytophysiology, Faculty of Biology and Environmental Protection, University of Lodz) ;
  • Marczak, Agnieszka (Department of Thermobiology, Faculty of Biology and Environmental Protection, University of Lodz)
  • Published : 2016.01.11


The purpose of this study was to provide a detailed explanation of the mechanism of bisanthracycline, WP 631 in comparison to doxorubicin (DOX), a first generation anthracycline, currently the most widely used pharmaceutical in clinical oncology. Experiments were performed in SKOV-3 ovarian cancer cells which are otherwise resistant to standard drugs such as cis-platinum and adriamycin. As attention was focused on the ability of WP 631 to induce apoptosis, this was examined using a double staining method with Annexin V and propidium iodide probes, with measurement of the level of intracellular calcium ions and cytosolic cytochrome c. The western blotting technique was performed to confirm PARP cleavage. We also investigated the involvement of caspase activation and DNA degradation (comet assay and immunocytochemical detection of phosphorylated H2AX histones) in the development of apoptotic events. WP 631 demonstrated significantly higher effectiveness as a pro-apoptotic drug than DOX. This was evident in the higher levels of markers of apoptosis, such as the externalization of phosphatidylserine and the elevated level of cytochrome c. An extension of incubation time led to an increase in intracellular calcium levels after treatment with DOX. Lower changes in the calcium content were associated with the influence of WP 631. DOX led to the activation of all tested caspases, 8, 9 and 3, whereas WP 631 only induced an increase in caspase 8 activity after 24h of treatment and consequently led to the cleavage of PARP. The lack of active caspase 3 had no outcome on the single and double-stranded DNA breaks. The obtained results show that WP 631 was considerably more genotoxic towards the investigated cell line than DOX. This effect was especially visible after longer times of incubation. The above detailed studies indicate that WP 631 generates early apoptosis and cell death independent of caspase-3, detected at relatively late time points. The observed differences in the mechanisms of the action of WP631 and DOX suggest that this bisanthracycline can be an effective alternative in ovarian cancer treatment.


WP 631;ovarian cancer cells;anthracyclines;apoptosis;DNA damage;caspases


Supported by : Ministry of Science and High Education (Poland)


  1. Yang F, Teves SS, Kemp CJ, et al (2014). Doxorubicin, DNA torsion, and chromatin dynamics. Biochim Biophys Acta, 1, 84-9.
  2. Zabka A, Trzaskoma P, Maszewski J (2013). Dissimilar effects of ${\beta}$-lapachone- and hydroxyurea-induced DNA replication stress in root meristem cells of Allium cepa. Plant Physiol Biochem, 73, 282-93.
  3. Zhao D, Wu LY, Wang XB, et al (2015). Role of neoadjuvant chemotherapy in the management of advanced ovarian cancer. Asian Pac J Cancer Prev, 6, 2369-73.
  4. Rochette L, Guenancia C, Gudjoncik A, et al (2015). Anthracyclines/trastuzumab: new aspects of cardiotoxicity and molecular mechanisms. Trends Pharmacol Sci, 6, 326-48.
  5. Rogalska A, Gajek, Szwed M, et al (2011). The role of reactive oxygen species in WP 631-induced A death of human ovarian cancer cells: a comparison with the effect of doxorubicin. Toxicol In Vitro, 8, 1712-20.
  6. Rogalska A, Szwed M, Jozwiak Z (2010). Aclarubicin-induced apoptosis and necrosis in cells derived from human solid tumours. Mutat Res, 700, 1-10.
  7. Shirinbayan V, Roshan VD (2012). Pretreatment effect of running exercise on HSP70 and DOX-induced cardiotoxicity. Asian Pac J Cancer Prev, 11, 5849-55.
  8. Siegel R, Naishadham D, Jemal A (2013). Cancer statistics. CA Cancer J Clin, 63, 11-30.
  9. Sundar S, Neal RD, Kehoe S (2015). Diagnosis of ovarian cancer. BMJ, 1, 351-4443.
  10. Suprasert P, Manopunya M, Cheewakriangkrai C (2014). Outcomes with single agent LIPO-DOX in platinumresistant ovarian and fallopian tube cancers and primary peritoneal adenocarcinoma - Chiang Mai University Hospital experience. Asian Pac J Cancer Prev, 3, 1145-8.
  11. Surova O, Zhivotovsky B (2013). Various modes of cell death induced by DNA damage. Oncogene, 32, 3789-97.
  12. Suzuki J, Fujii T, Imao T, et al (2013). Calcium-dependent Phospholipid Scramblase Activity of TMEM16 Protein Family Members. J Biol Chem, 19, 13305-16.
  13. Szwed M, Jozwiak Z (2014). Genotoxic effect of doxorubicintransferrin conjugate on human leukemia cells. Mutat Res Genet Toxicol Environ Mutagen, 771, 53-63.
  14. Szwed M, Laroche-Clary A, Robert J, et al (2014). Induction of apoptosis by doxorubicin-transferrin conjugate compared to free doxorubicin in the human leukemia cell lines. Chem Biol Interact, 220, 140-8.
  15. Treude F, Kappes F, Fahrenkamp D, et al (2014). Caspase-8-mediated PAR-4 cleavage is required for $TNF{\alpha}$-induced apoptosis. Oncotarget, 10, 2988-98.
  16. Verhoven B, Krahling S, Schlegel RA, et al (1999). Regulation of phosphatidylserine exposure and phagocytosis of apoptotic T lymphocytes. Cell Death Differ, 3, 262-70.
  17. Weisthal S, Keinan N, Ben-Hail D, et al (2014). Ca(2+)-mediated regulation of VDAC1 expression levels is associated with cell death induction. Biochim Biophys Acta, 10, 2270-81.
  18. Wojcik T, Buczek E1, Majzner K, et al (2015). Comparative endothelial profiling of doxorubicin and daunorubicin in cultured endothelial cells. Toxicol In Vitro, 3, 512-21.
  19. Xue X, Yu JL, Sun DQ, et al (2014). Curcumin induces apoptosis in SGC-7901 gastric adenocarcinoma cells via regulation of mitochondrial signaling pathways. Asian Pac J Cancer Prev, 9, 3987-92.
  20. Yamashita A, Morikawa H, Tajima N, et al (2012). Mechanisms Underlying Production And Externalization of Oxidized Phosphatidylserine in Apoptosis: Involvement of Mitochondria. Yonago Acta Med, 1, 11-20.
  21. Joshi M, Sodhi KS, Pandey R, et al (2015). Duxorubicin-induced cardiotoxicity. Int J Basic Clin Pharmacol, 1, 6-14.
  22. Kim EA, Jang JH, Lee YH, et al (2014). Dioscin induces caspaseindependent apoptosis through activation of apoptosisinducing factor in breast cancer cells. Apoptosis, 7, 1165-75.
  23. Kimani SG, Geng K, Kasikara C, et al (2014). Contribution of Defective PS Recognition and Efferocytosis to Chronic Inflammation and Autoimmunity. Birge Front Immunol, 5, 566.
  24. Kmit A, van Kruchten R, Ousingsawat J, et al (2013). Calciumactivated and apoptotic phospholipid scrambling induced by Ano6 can occur independently of Ano6 ion currents. Cell Death and Disease. Cell Death Dis, 4, 611.
  25. Ko HL, Ren EC (2012). Functional Aspects of PARP1 in DNA repair and transcription. Biomolecules, 2, 524-48.
  26. Lee K, Hart MR, Briehl MM, et al (2014). The copper chelator ATN-224 induces caspase-independent cell death in diffuse large B cell lymphoma. Int J Oncol, 1, 439-47.
  27. Liu JR, Opipari AW, Tan L, et al (2002). Dysfunctional apoptosome activation in ovarian cancer: implications for chemoresistance. Cancer Res, 3, 924-31.
  28. Marczak A, Denel-Bobrowska M, Lukawska M, et al (2015). Formamidinodoxorubicins are more potent than doxorubicin as apoptosis inducers in human breast cancer cells. Anticancer Res, 4, 1935-40.
  29. Mei L, Hu Q, Peng J, et al (2015). Phospho-histone H2AX is a diagnostic and prognostic marker for epithelial ovarian cancer. Int J Clin Exp Pathol, 5, 5597-602.
  30. Pal S, Ahir M, Sil PC (2012). Doxorubicin-induced neurotoxicity is attenuated by a 43-kD protein from the leaves of Cajanus indicus L. via $NF-{\kappa}B$ and mitochondria dependent pathways. Free Radic Res, 6, 785-98.
  31. Parrish AB, Freel CD, Kornbluth S (2013). Cellular mechanisms controlling caspase activation and function. Cold Spring Harb Perspect Biol, 5, 8672.
  32. Portugal J, Cashman DJ, Trent JO, et al (2005). A new bisintercalating anthracycline with picomolar DNA binding affinity. J Med Chem, 48, 8209-19.
  33. Pradjatmo H, Dasuki D, Anwar M, et al (2014). Methylation status and immunohistochemistry of BRCA1 in epithelial ovarian cancer. Asian Pac J Cancer Prev, 21, 9479-85.
  34. Boucher D, Blais V, Denault JB (2012). Caspase-7 uses an exosite to promote poly (ADP ribose) polymerase 1 proteolysis. Proc Natl Acad Sci U S A, 15, 5669-74.
  35. Carvalho FS, Burgeiro A, Garcia R, et al (2014). Doxorubicin-Induced Cardiotoxicity: From Bioenergetic Failure and Cell Death to Cardiomyopathy. Med Res Rev, 34, 106-35.
  36. Catala A (2015). Lipid peroxidation modifies the assembly of biological membranes "The Lipid Whisker Model". Front Physiol, 5, 520.
  37. Chaopotong P, Therasakvichya S, Leelapatanadit C, et al (2015). Ovarian cancer in children and adolescents: treatment and reproductive outcomes. Asian Pac J Cancer Prev, 11, 4787-90.
  38. Fujiwara K, Kurosaki A, Hasegawa K (2013). Clinical trials of neoadjuvant chemotherapy for ovarian cancer: what do we gain after an eortc trial and after two additional ongoing trials are completed? Curr Oncol Rep, 3, 197-200.
  39. Gajek A, Denel M, Bukowska B, et al (2014). Pro-apoptotic activity of new analog of anthracyclines-WP 631 in advanced ovarian cancer cell line. Toxicol In Vitro, 2, 273-81.
  40. Garnier P, Ying W, Swanson RA (2003). Ischemic preconditioning by caspase cleavage of poly(ADP-ribose) polymerase-1. J Neurosci, 22, 7967-73.
  41. Goldar S, Khaniani MS, Derakhshan SM, et al (2015). Molecular mechanisms of apoptosis and roles in cancer development and treatment. Asian Pac J Cancer Prev, 16, 2129-44.
  42. Ikeda M, Kurose A, Takatori E, et al (2010). DNA damage detected with ${\gamma}H2AX$ in endometrioid adenocarcinoma cell lines. Int J Oncol, 5, 1081-88.
  43. Jayashree BS, Nigam S, Pai A, et al (2015). Targets in anticancer research-A review. Indian J Exp Biol, 8, 489-507.
  44. Jimenez IJ, Garcia Casado Z, Palanca Suela S, et al (2013). Novel and recurrent BRCA1/BRCA2 mutations in early onset and familial breast and ovarian cancer detected in the program of genetic counseling in cancer of valencian community (eastern Spain). Relationship of family phenotypes with mutation prevalence. Fam Cancer, 4, 767-77.

Cited by

  1. Integration of Ca2+ signaling regulates the breast tumor cell response to simvastatin and doxorubicin vol.37, pp.36, 2018,